BSE filing, NSE: IOLCP. Summary written from the filing by ALFA Finder's alert engine.
IOL Chemicals and Pharmaceuticals Ltd: key numbers
- Share price
- ₹184.93
- Market cap
- ₹5,428 Cr
- Revenue (annual)
- ₹2,319 Cr
- Net profit (annual)
- ₹137.6 Cr
- P/E (TTM)
- 32.3×Sector 48.7×
- Promoter holding
- 62.28%+0.00% QoQ
- FII holding
- 7.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IOL Chemicals and Pharmaceuticals Ltd
All →IOL Chemicals and Pharmaceuticals Other Announcement
The company submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulations.
IOL Chemicals and Pharmaceuticals Regulatory Approval
IOL Chemicals and Pharmaceuticals Limited received EU-REACH registration for its product 'Triacetin', enabling the company to export this product to countries in the European Union.
IOL Chemicals and Pharmaceuticals Other Announcement
IOL Chemicals and Pharmaceuticals Limited informed the Exchange about the dispatch of reminder letters to shareholders holding physical shares for updating their KYC details.
IOL Chemicals and Pharmaceuticals Earnings Call Transcript: Key Takeaways
IOL Chemicals announced three strategic initiatives involving INR 500 Cr investment: Ibuprofen capacity expansion (to 18,000 MTPA), a new CDMO formulations facility, and a dedicated specialty chemical tolling facility.
- Call
- Guides 20% growth
IOL Chemicals and Pharmaceuticals Capacity Expansion: ₹350 Cr Investment
IOL Chemicals and Pharmaceuticals Ltd will expand Ibuprofen capacity by 6,000 MTPA. The project, requiring a ₹350 Crore investment, is expected to be commercialized by December 2027.
- Value
- ₹350.0 Cr
- Execution
- December 2027
- manufacturing capacity
- 6000.0 MTPA
IOL Chemicals and Pharmaceuticals Capacity Expansion: ₹495 Cr Investment
IOLCP announces three capacity expansions at Barnala: 6,000 MTPA Ibuprofen unit, CDMO formulation facility, and specialty chemicals tolling plant. Total investment ₹495 Crore funded via internal accruals.
- Value
- ₹495.0 Cr
- ibuprofen manufacturing capacity
- 6000 MTPA
Other board meeting date announcements
All →Mishtann Foods Board Meeting Date
Mishtann Foods has scheduled its board meeting for November 4, 2026, to approve Q1 and H1 FY27 unaudited financial results. No other material agenda items are disclosed.
G S Auto International Board Meeting Date
GS Auto International has scheduled its Board meeting for 06 Nov 2026 to consider un-audited Q2 and H1 FY27 results. No financial figures are disclosed in this prior intimation.
Raj Packaging Industries Board Meeting Date
Raj Packaging Industries intimated that its Board will meet on 06/11/2026 to approve unaudited results for the quarter and half year ended 30/09/2026. The trading window is closed from 01/10/2026 to 08/11/2026.
Panasonic Carbon India Co Board Meeting Date
Panasonic Carbon India will hold its Board meeting on 05/11/2026 to consider unaudited H1 FY27 results. The filing is a prior intimation with the trading window closed till 07/11/2026.
Standard Batteries Board Meeting Date
Standard Batteries Ltd announced its 12 November 2026 Board meeting to consider un-audited Q1 and H1 FY27 results. The trading window is closed from 1 October 2026.
Vardhman Textiles Board Meeting Date
Vardhman Textiles scheduled its Board meeting for 6 November 2026. The agenda includes approval of un-audited financial results for the half-year ended 30 September 2026.